Perkins Capital Management Has Lifted Its Iridex (IRIX) Position by $936,000; Market Valuation Declined; As Moelis & Co (MC) Market Value Declined, Morgan Stanley Has Increased Position

Moelis & Company (NYSE:MC) Logo

Perkins Capital Management Inc increased its stake in Iridex Corp (IRIX) by 216.82% based on its latest 2018Q3 regulatory filing with the SEC. Perkins Capital Management Inc bought 156,000 shares as the company’s stock declined 51.78% with the market. The institutional investor held 227,950 shares of the electromedical & electrotherapeutic apparatus company at the end of 2018Q3, valued at $1.45 million, up from 71,950 at the end of the previous reported quarter. Perkins Capital Management Inc who had been investing in Iridex Corp for a number of months, seems to be bullish on the $70.42M market cap company. The stock increased 7.92% or $0.38 during the last trading session, reaching $5.18. About 9,105 shares traded. IRIDEX Corporation (NASDAQ:IRIX) has declined 47.56% since January 9, 2018 and is downtrending. It has underperformed by 47.56% the S&P500. Some Historical IRIX News: 20/03/2018 – IRIDEX GETS CE MARK FOR TRANSILLUMINATED PROBE; 03/05/2018 – Iridex Sees 2018 Rev $37M-$41M; 20/03/2018 – lridex Receives CE Mark for Transilluminated Probe; 19/04/2018 – DJ IRIDEX Corporation, Inst Holders, 1Q 2018 (IRIX); 08/03/2018 Iridex 4Q Loss/Shr 44c; 16/04/2018 – IRIDEX Announces Appointment of Maria Sainz and David Bruce to Its Bd of Directors; 03/05/2018 – Iridex 1Q Rev $9.51M; 16/03/2018 – FDA: Iridex Corporation- Iridex TruFocus LIO Premiere” Laser Indirect Ophthalmoscope ( LIO ) The LIO is a headmounted i; 20/03/2018 – Iridex Receives CE Mark for Transilluminated Probe; 08/03/2018 – IRIDEX CORP – QTRLY SHR LOSS $0.44

Morgan Stanley increased its stake in Moelis & Co (MC) by 4.15% based on its latest 2018Q3 regulatory filing with the SEC. Morgan Stanley bought 19,018 shares as the company’s stock declined 31.81% with the market. The institutional investor held 477,740 shares of the investment managers company at the end of 2018Q3, valued at $26.18M, up from 458,722 at the end of the previous reported quarter. Morgan Stanley who had been investing in Moelis & Co for a number of months, seems to be bullish on the $2.16B market cap company. The stock increased 1.15% or $0.42 during the last trading session, reaching $36.81. About 315,840 shares traded. Moelis & Company (NYSE:MC) has declined 14.79% since January 9, 2018 and is downtrending. It has underperformed by 14.79% the S&P500. Some Historical MC News: 12/03/2018 – Moelis & Co Commences Public Offering of Class a Common Stk; 03/04/2018 – La Colombe Said to Hire Moelis in Bid for $1 Billion Valuation; 05/03/2018 MOVES-Chubb, Deutsche Asset Management, Euromoney, BOfA Merrill, Moelis; 19/03/2018 – MEDIWOUND LTD – BOARD HAS RETAINED MOELIS & COMPANY LLC TO ASSIST US IN EVALUATION OF POTENTIAL OPPORTUNITY; 06/03/2018 – MOVES-State Street, Aon, HSBC, Moelis; 10/05/2018 – CLAL BIO: MEDIWOUND USING SERVICES OF M&A SPECIALIST MOELIS; 22/03/2018 – MOVES- Credit Suisse, Moelis, Ernst & Young; 22/03/2018 – Moelis Adds Morgan Stanley’s Thompson for Health-Care Dealmaking; 29/05/2018 – MOELIS AUSTRALIA SAYS SALE LESS THAN 8% OF OVERALL EXEC HOLDING; 22/03/2018 – MOVES-Moelis names Joel Thompson managing director

Investors sentiment increased to 1.78 in Q3 2018. Its up 0.98, from 0.8 in 2018Q2. It improved, as 2 investors sold IRIX shares while 7 reduced holdings. 6 funds opened positions while 10 raised stakes. 7.05 million shares or 30.11% more from 5.42 million shares in 2018Q2 were reported. Renaissance Technologies Lc holds 0% or 335,500 shares in its portfolio. Neuberger Berman Group Lc invested 0% of its portfolio in IRIDEX Corporation (NASDAQ:IRIX). Driehaus Cap Limited Liability Corp has 0.05% invested in IRIDEX Corporation (NASDAQ:IRIX) for 280,000 shares. Quantum invested in 0.04% or 15,740 shares. Wasatch Advisors Inc reported 0.1% of its portfolio in IRIDEX Corporation (NASDAQ:IRIX). Geode Cap Mgmt Ltd Limited Liability Company reported 38,849 shares stake. Royal Bancshares Of Canada holds 0% of its portfolio in IRIDEX Corporation (NASDAQ:IRIX) for 27 shares. California Employees Retirement, a California-based fund reported 32,100 shares. Bnp Paribas Arbitrage Sa accumulated 0% or 32 shares. Blackrock holds 37,287 shares or 0% of its portfolio. Destination Wealth Management stated it has 0% in IRIDEX Corporation (NASDAQ:IRIX). Finemark Natl Bank holds 36,365 shares. Thompson Davis And invested in 0.01% or 500 shares. Osborne Prns Cap Management Limited Liability Co, a California-based fund reported 57,000 shares. Bridgeway Cap Inc holds 81,500 shares or 0.01% of its portfolio.

Among 4 analysts covering IRIDEX (NASDAQ:IRIX), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. IRIDEX had 7 analyst reports since January 26, 2016 according to SRatingsIntel. The firm has “Buy” rating by Roth Capital given on Wednesday, December 21. The company was initiated on Tuesday, January 26 by Singular Research. The company was maintained on Sunday, February 25 by Roth Capital. The company was initiated on Wednesday, December 21 by TH Capital. Stifel Nicolaus maintained IRIDEX Corporation (NASDAQ:IRIX) on Friday, January 4 with “Buy” rating.

Since September 14, 2018, it had 7 buys, and 0 insider sales for $671,654 activity. Another trade for 10,857 shares valued at $45,878 was made by Grove Robert Earle on Monday, December 10. Another trade for 10,000 shares valued at $47,144 was bought by MOORE WILLIAM M.

More notable recent IRIDEX Corporation (NASDAQ:IRIX) news were published by: Benzinga.com which released: “24 Stocks Moving In Friday’s Pre-Market Session – Benzinga” on September 14, 2018, also Globenewswire.com with their article: “IRIDEX Issues Voluntary Recall of TruFocus LIO Premiereâ„¢ Laser Indirect Ophthalmoscope – GlobeNewswire” published on February 23, 2018, Seekingalpha.com published: “IRIDEX Corporation (IRIX) CEO William Moore on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” on November 04, 2018. More interesting news about IRIDEX Corporation (NASDAQ:IRIX) were released by: Globenewswire.com and their article: “IRIDEX Announces Departure of Chief Financial Officer and Reiterates Full Year 2018 Guidance – GlobeNewswire” published on December 04, 2018 as well as Nasdaq.com‘s news article titled: “IRIDEX Announces Preliminary Operational and Financial Results for 2018 Fourth Quarter and Full Year – Nasdaq” with publication date: January 08, 2019.

Morgan Stanley, which manages about $60.09B and $399.53 billion US Long portfolio, decreased its stake in Weibo Corp (NASDAQ:WB) by 63,662 shares to 228,756 shares, valued at $16.73 million in 2018Q3, according to the filing. It also reduced its holding in Loxo Oncology Inc (NASDAQ:LOXO) by 44,394 shares in the quarter, leaving it with 88,013 shares, and cut its stake in Hanesbrands Inc (NYSE:HBI).

Among 14 analysts covering Moelis & Co (NYSE:MC), 6 have Buy rating, 0 Sell and 8 Hold. Therefore 43% are positive. Moelis & Co had 45 analyst reports since August 11, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained it with “Hold” rating and $5700 target in Monday, April 23 report. On Monday, June 5 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”. The company was maintained on Thursday, February 8 by Sandler O’Neill. The firm has “Overweight” rating by Morgan Stanley given on Thursday, October 26. The rating was maintained by JMP Securities with “Market Outperform” on Tuesday, July 25. As per Wednesday, January 10, the company rating was maintained by Keefe Bruyette & Woods. The rating was maintained by Keefe Bruyette & Woods on Thursday, December 21 with “Hold”. The stock has “Buy” rating by UBS on Thursday, October 29. The rating was upgraded by Bruyette & Woods” to “Outperform” on Tuesday, August 11. The company was upgraded on Tuesday, August 11 by Wood.

IRIDEX Corporation (NASDAQ:IRIX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.